We next tested the association of age acceleration with plasma AD biomarkers to test effects of biological aging with chronological age regressed out (Figure 4B and Tables S7–S9) and considered associations significant if we identified FDR‐significance with either clock (or both). This evidence concerns the gene CLOCK and Alzheimer disease.